CIPHERGEN BIOSYSTEMS INC 4
4 · CIPHERGEN BIOSYSTEMS INC · Filed Aug 29, 2003
Insider Transaction Report
Form 4
CALLAGHAN MICHAEL J
Director
Transactions
- Sale
Common Stock
2003-08-27$10.35/sh−10,000$103,527→ 1,109,636 total(indirect: See Footnote) - Sale
Common Stock
2003-08-28$10.26/sh−30,445$312,262→ 1,079,191 total(indirect: See Footnote)
Holdings
- 20,000
Common Stock
Footnotes (3)
- [F1]10,000 + 30,445 common shares disposed of by The Health Care and Biotechnology Venture Fund. Michael Callaghan is an officer of MDS Capital Corp., the manager of The Health Care and Biotechnology Venture Fund. Mr. Callaghan disclaims beneficial ownership over these shares.
- [F2]1,079,191 shares remaining (after giving effect to the August 27 and 28, 2003 dispositions) reflects common shares held by the following entities in the following respective amounts. Each of these entities disclaims beneficial ownership of the shares held by the other entities. Michael Callaghan disclaims beneficial ownership of these shares. 180,969 MDS Life Sciences Technology Fund USA, L.P. 132,826 MDS Life Sciences Technology Barbados Investment Trust 765,396 MDS Life Sciences Technology Fund Limited Partnership 0 The Health Care and Biotechnology Venture Fund
- [F3]20,000 held by Mr. Callaghan for the benefit of the entities described in Footnote 2 above. Michael Callaghan disclaims beneficial ownership of all such shares.